Cardlytics price target lowered to $1.25 from $1.50 at Lake Street

Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $1.25 from $1.50 and keeps a Hold rating on the shares. With Q1 guidance resetting numbers across the board, the firm believes “the bar is appropriately level set” to reflect the near-term impact of the BofA exit and Bridg divestiture, though it adds that shares remain in “show me” territory.